1
|
Al Azzam KM, Aboul-Enein HY. Recent advances in analysis of hazardous genotoxic impurities in pharmaceuticals by HPLC, GC, and CE. J LIQ CHROMATOGR R T 2016. [DOI: 10.1080/10826076.2015.1111794] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- Khaldun M. Al Azzam
- Department of Pharmaceutical Chemistry, Pharmacy Program, Batterjee Medical College for Sciences and Technology (BMC), Jeddah, Kingdom of Saudi Arabia
| | - Hassan Y. Aboul-Enein
- Department of Pharmaceutical and Medicinal Chemistry, Pharmaceutical and Drug Industries Research Division, National Research Center, Dokki, Giza, Egypt
| |
Collapse
|
2
|
Reddy AVB, Jaafar J, Umar K, Majid ZA, Aris AB, Talib J, Madhavi G. Identification, control strategies, and analytical approaches for the determination of potential genotoxic impurities in pharmaceuticals: A comprehensive review. J Sep Sci 2015; 38:764-79. [DOI: 10.1002/jssc.201401143] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2014] [Revised: 12/12/2014] [Accepted: 12/16/2014] [Indexed: 11/06/2022]
Affiliation(s)
| | - Jafariah Jaafar
- Department of Chemistry; Faculty of Science; Universiti Teknologi Malaysia; Johor Malaysia
| | - Khalid Umar
- Department of Environmental Engineering; Faculty of Civil Engineering; Universiti Teknologi Malaysia; Johor Malaysia
| | - Zaiton Abdul Majid
- Department of Chemistry; Faculty of Science; Universiti Teknologi Malaysia; Johor Malaysia
| | - Azmi Bin Aris
- Department of Environmental Engineering; Faculty of Civil Engineering; Universiti Teknologi Malaysia; Johor Malaysia
| | - Juhaizah Talib
- Department of Environmental Engineering; Faculty of Civil Engineering; Universiti Teknologi Malaysia; Johor Malaysia
| | | |
Collapse
|
3
|
Yamamoto E, Niijima J, Asakawa N. Selective determination of potential impurities in an active pharmaceutical ingredient using HPLC-SPE-HPLC. J Pharm Biomed Anal 2013; 84:41-7. [DOI: 10.1016/j.jpba.2013.05.033] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2013] [Revised: 05/21/2013] [Accepted: 05/22/2013] [Indexed: 11/26/2022]
|
4
|
Ho TD, Joshi MD, Silver MA, Anderson JL. Selective extraction of genotoxic impurities and structurally alerting compounds using polymeric ionic liquid sorbent coatings in solid-phase microextraction: Alkyl halides and aromatics. J Chromatogr A 2012; 1240:29-44. [DOI: 10.1016/j.chroma.2012.03.080] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2012] [Revised: 03/23/2012] [Accepted: 03/26/2012] [Indexed: 11/16/2022]
|
5
|
Giordani A, Kobel W, Gally HU. Overall impact of the regulatory requirements for genotoxic impurities on the drug development process. Eur J Pharm Sci 2011; 43:1-15. [PMID: 21420491 DOI: 10.1016/j.ejps.2011.03.004] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2010] [Revised: 01/18/2011] [Accepted: 03/05/2011] [Indexed: 11/19/2022]
Abstract
In the last decade a considerable effort has been made both by the regulators and the pharmaceutical industry to assess genotoxic impurities (GTI) in pharmaceutical products. Though the control of impurities in drug substances and products is a well established and consolidated procedure, its extension to GTI has given rise to a number of problems, both in terms of setting the limits and detecting these impurities in pharmaceutical products. Several papers have dealt with this issue, discussing available regulations, providing strategies to evaluate the genotoxic potential of chemical substances, and trying to address the analytical challenge of detecting GTI at trace levels. In this review we would like to discuss the available regulations, the toxicological background for establishing limits, as well as the analytical approaches used for GTI assessment. The final aim is that of providing a complete overview of the topic with updated available information, to address the overall GTI issue during the development of new drug substances.
Collapse
|
6
|
Lee C, Helmy R, Strulson C, Plewa J, Kolodziej E, Antonucci V, Mao B, Welch CJ, Ge Z, Al-Sayah MA. Removal of Electrophilic Potential Genotoxic Impurities Using Nucleophilic Reactive Resins. Org Process Res Dev 2010. [DOI: 10.1021/op1000397] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Claire Lee
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Roy Helmy
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Christopher Strulson
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Jolanta Plewa
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Elizabeth Kolodziej
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Vincent Antonucci
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Bing Mao
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Christopher J. Welch
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Zhihong Ge
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| | - Mohammad A. Al-Sayah
- Merck & Co. Inc., Building 818-B218, P.O. Box 2000, Rahway, New Jersey 07065, U.S.A
| |
Collapse
|
7
|
Liu DQ, Sun M, Kord AS. Recent advances in trace analysis of pharmaceutical genotoxic impurities. J Pharm Biomed Anal 2010; 51:999-1014. [DOI: 10.1016/j.jpba.2009.11.009] [Citation(s) in RCA: 79] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2009] [Revised: 11/03/2009] [Accepted: 11/08/2009] [Indexed: 10/20/2022]
|
8
|
Enhancing the detection sensitivity of trace analysis of pharmaceutical genotoxic impurities by chemical derivatization and coordination ion spray-mass spectrometry. J Chromatogr A 2010; 1217:302-6. [DOI: 10.1016/j.chroma.2009.11.048] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2009] [Revised: 11/12/2009] [Accepted: 11/17/2009] [Indexed: 11/23/2022]
|